On January 4, 2021 United Therapeutics Corporation (Nasdaq: UTHR) reported that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business during a presentation and question and answer session at the 39th annual J.P. Morgan Healthcare Conference (Press release, United Therapeutics, JAN 4, 2021, View Source [SID1234573421]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will take place virtually on Monday, January 11, 2021, from 10:50 a.m. to 11:30 a.m., Eastern Standard Time, and can be accessed via a live webcast on the United Therapeutics website at View Source An archived, recorded version of the presentation will be available approximately 24 hours after the session ends and can be accessed at the same location for 30 days.